| Application note |
Improving the stem cell characterization workflow: better colony identification using live-cell reagents that enable simultaneous detection of positive and negative pluripotency markers |
| Application note |
Lipofectamine 3000 Reagent: Generation and transfection of induced pluripotent stem cells |
| Application note |
Nunclon Sphera and Stem Cell EB formation application note |
| Application note |
Single cell passaging methods |
| FAQ |
Cell Therapy Systems |
| FAQ |
CytoTune-iPS 2.0 Sendai Reprogramming Kit and CytoTune EmGFP Sendai Fluorescence Reporter FAQ |
| FAQ |
Epi5 Episomal iPSC Reprogramming Kit FAQ |
| FAQ |
Episomal iPSC Reprogramming Vectors FAQ |
| FAQ |
Essential 8 Flex Medium |
| FAQ |
Essential 8 Medium |
| FAQ |
Essential 8 Medium and Vitronectin |
| FAQ |
Laminin-521/Adaptation Kit |
| FAQ |
RevitaCell Supplement |
| FAQ |
TaqMan hPSC Scorecard Panel FAQ |
| Handbook |
Antibodies for Stem Cell Research Handbook |
| Handbook |
Gibco Neurobiology Protocol Handbook |
| Handbook |
Pluripotent Stem Cell Guidebook |
| Handbook |
Pluripotent Stem Cell Handbook |
| Handbook |
Pluripotent Stem Cell Protocol Handbook |
| Literature |
Cell reprogramming tools |
| Literature |
Cell Therapy Systems brochure |
| Literature |
Essential 8 Media brochure |
| Literature |
Improving the stem cell characterization workflow: Confirming differentiation potential via multi-color detection of germ layer markers |
| Literature |
Nunc Cell Culture Imaging Brochure |
| Literature |
TaqMan hPSC Scorecard Panel and Software |
| Newsletter |
Stem Cell Intel |
| Protocol |
3-Germ Layer Immunocytochemistry Kit |
| Protocol |
A introduction to stem cell maintenance |
| Protocol |
Adaptation of hPSCs from different culture systems to Essential 8 Medium or Essential 8 Flex Medium |
| Protocol |
Creation of embryoid bodies from iPSCs using Complete KnockOut Serum Replacement Feeder-Free Medium |
| Protocol |
Culturing human embryonic stem cells on MEF-conditioned medium |
| Protocol |
Culturing induced pluripotent stem cells (iPSCs) on MEF-conditioned medium |
| Protocol |
Culturing PSCs in Essential 8 Medium |
| Protocol |
CytoTune EmGFP Sendai Fluorescence Reporter |
| Protocol |
CytoTune-iPS 2.0 Sendai Reprogramming Kit |
| Protocol |
Derivation of dopaminergic neurons from human embryonic stem cells |
| Protocol |
Detecting pluripotency with Alkaline Phosphatase Live Stain |
| Protocol |
Differentiating glial precursor cells into astrocytes and oligodendrocytes |
| Protocol |
Differentiating neural stem cells into neurons and glial cells |
| Protocol |
Enrichment and replating of PSC-derived cardiomyocytes |
| Protocol |
Epi5 Episomal iPSC Reprogramming Kit |
| Protocol |
Episomal iPSC Reprogramming Vectors |
| Protocol |
Essential 6 Medium |
| Protocol |
Essential 8 Adaptation Kit |
| Protocol |
Essential 8 Flex Medium |
| Protocol |
Essential 8 Medium |
| Protocol |
Feeder-dependent culture and passaging mouse embryonic stem cells (mESCs) in KnockOut Serum Replacement with leukemia inhibitory factor (LIF) |
| Protocol |
Feeder-dependent culture of human embryonic stem cells (hESCs) |
| Protocol |
Feeder-dependent culture of human induced pluripotent stem cells (hiPSCs) |
| Protocol |
Formation of embryoid bodies (EBs) from mouse embryonic stem cells (mESCs) |
| Protocol |
Geltrex LDEV-Free, hESC-qualified, Reduced Growth Factor Basement Membrane Matrix |
| Protocol |
General Stem Cell Protocols |
| Protocol |
Generation of Human Induced Pluripotent Stem Cells (hiPSC) from Fibroblasts using Episomal Vectors |
| Protocol |
Gibco Episomal hiPSC Line |
| Protocol |
hPSC Scorecard Analysis Software |
| Protocol |
Human Cardiomyocyte Immunocytochemistry Kit |
| Protocol |
Human Dopaminergic Neuron Immunocytochemistry Kit |
| Protocol |
Human Neural Stem Cell Immunocytochemistry Kit |
| Protocol |
Induction of neural stem cells from human pluripotent stem cells using Gibco PSC Neural Induction Medium |
| Protocol |
Mouse (ICR) Inactivated Embryonic Fibroblasts |
| Protocol |
Neural Stem Cell Protocols |
| Protocol |
Pluripotent Stem Cell Protocols |
| Protocol |
PSC 4-Marker Immunocytochemistry Kit (OCT4, SSEA4, SOX2, TRA-1-60) |
| Protocol |
PSC Cardiomyocyte Differentation Kit |
| Protocol |
PSC Cardiomyocyte Differentation Kit quick reference guide |
| Protocol |
PSC Definitive Endoderm Induction Kit |
| Protocol |
PSC Definitive Endoderm Induction Kit quick reference guide |
| Protocol |
PSC Dopaminergic Neuron Differentiation Kit (prototype) |
| Protocol |
PSC Neural Induction Medium |
| Protocol |
PSC Neural Induction Medium quick reference guide |
| Protocol |
Reprogramming peripheral blood mononuclear cells (PBMCs) with the CytoTune-iPS 2.0 Reprogramming Kit under feeder-free conditions |
| Protocol |
RevitaCell Supplement |
| Protocol |
Single-cell dissociation of PSCs for cardiomyocyte differentiation |
| Protocol |
StemPro hESC SFM |
| Protocol |
TaqMan hPSC Scorecard Panel Quick Reference Card |
| Protocol |
Using the TaqMan hPSC Scorecard Panel |
| Protocol |
Vitronectin, truncated recombinant human (VTN-N) |
| Publication |
A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells |
| Publication |
A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific iPSCs |
| Publication |
An efficient method for the derivation of mouse embryonic stem cells |
| Publication |
Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai virus vectors |
| Publication |
Cellular reprogramming of human peripheral blood cells |
| Publication |
Characterization of human Huntington's Disease cell model from induced pluripotent stem cells |
| Publication |
Chemically defined conditions for human iPSC derivation and culture |
| Publication |
Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture |
| Publication |
Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7 |
| Publication |
Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor |
| Publication |
Defined hPSC culture enables highly efficient neuroepithelium derivation without small molecule inhibitors |
| Publication |
Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells |
| Publication |
Derivation of induced pluripotent stem cells from pig somatic cells |
| Publication |
Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation |
| Publication |
Disease-specific induced pluripotent stem cells |
| Publication |
Efficient and rapid generation of induced pluripotent stem cells using an alternative culture medium |
| Publication |
Efficient feeder-free episomal reprograming with small molecules |
| Publication |
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord bloodmononuclear cells |
| Publication |
Efficient iPS cell production with the MyoD transactivation domain in serum-free culture |
| Publication |
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells |
| Publication |
Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing |
| Publication |
Feeder layer- and serum-free culture of human embryonic stem cells |
| Publication |
Feeder-free growth of undifferentiated human embryonic stem cells |
| Publication |
Generation of germline-competent rat induced pluripotent stem cells |
| Publication |
Generation of GFP reporter human induced pluripotent stem cells using AAVS1 safe harbor Transicription Activator Like Effector Nuclease |
| Publication |
Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors |
| Publication |
Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts |
| Publication |
Generation of induced pluripotent stem cells in the absence of drug selection |
| Publication |
Generation of novel rat and human pluripotent stem cells by reprogramming and chemical approaches |
| Publication |
Human dermal stem cells differentiate into functional epidermal melanocytes |
| Publication |
Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells |
| Publication |
Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons |
| Publication |
Improved generation of C57BL/6J mouse embryonic stem cells in a defined serum-free media |
| Publication |
Induced pluripotent stem cell reprogramming by integration-free sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia |
| Publication |
Induced pluripotent stem cells for neural tissue engineering |
| Publication |
Induction of pluripotent stem cells from adult human fibroblasts by defined factors |
| Publication |
Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds |
| Publication |
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 |
| Publication |
Isolation of single-base genome-edited human iPS cells with antiobiotic selection |
| Publication |
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor |
| Publication |
Motor Neuron Differentiation from Pluripotent Stem Cells and Other Intermediate Proliferative Precursors that can be Discriminated by Lineage Specific Reporters |
| Publication |
New cell lines from mouse epiblast share defining features with human embryonic stem cells |
| Publication |
Neural Cell Culture Publications Finder |
| Publication |
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency |
| Publication |
Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the non obese diabetic mouse |
| Publication |
Passaging and colony expansion of hPSCs by enzyme-free dissocation in chemically define culture conditions |
| Publication |
Publications citing the Sendai virus for iPSC generation |
| Publication |
Reprogramming of human somatic cells to pluripotency with defined factors |
| Publication |
Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors |
| Publication |
RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications |
| Publication |
Scalable expansion of human iPSCs in the defined xeno-free E8 medium under adherent and suspension culture conditions |
| Publication |
Serum-based culture conditions provoke gene expression variability in mouse embryonic stem cells as revealed by single-cell analysis |
| Publication |
Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines |
| Publication |
Signaling defects in iPSC-derived fragile X premutation neurons |
| Publication |
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells |
| Publication |
Unique gene expression signature by human embryonic stem cells cultured under serum-free conditions correlates with their enhanced and prolonged growth in an undifferentiated stage |
| Publication |
Whole-Genome Sequencing Analysis Reveals High Specificity of CRISPR/Cas9 and TALEN-Based Genome Editing in Human iPSCs |
| Poster |
The Power of Stem Cells |
| Scientific poster |
ISSCR 2017: Accelerating and synchronizing the differentiation of human pluripotent stem cell-derived neural stem cells into neurons by preventing cell proliferation |
| Scientific poster |
ISSCR 2017: Cell Therapy Systems (CTS) Sendai virus reprogramming kit for xeno-free generation of iPSCs |
| Scientific poster |
ISSCR 2017: Development of a robust, next-generation, feeder-free pluripotent stem cell medium |
| Scientific poster |
ISSCR 2017: Development of an improved feeder-free culture system for mouse pluripotent stem cells |
| Scientific poster |
ISSCR 2017: Effect of replacement of c-Myc with L-Myc on Sendai-based reprogramming method |
| Scientific poster |
ISSCR 2017: Impact of passaging method on iPSC quality during early clonal establishment |
| Scientific poster |
ISSCR 2017: New tools for improving the genome editing workflow in human induced pluripotent stem cell applications |
| Scientific poster |
ISSCR 2017: RNA Replicon platform to enable long-lasting transient expression in primary and stem cells |
| Scientific poster |
ISSCR 2017: Single-cell analysis of transcription factor expression during differentiation of PSC to cardiomyocytes using flow cytometry |
| Scientific poster |
A Novel Essential 8 Media System for Robust Weekend-Free Culture of Pluripotent Stem Cells |
| Scientific poster |
Antibody-based tools and protocols for improving stem cell characterization workflow |
| Scientific poster |
A robust platform for generation of hiPS-derived cardiomyocytes |
| Scientific poster |
Cell surface marker expression analysis to track progression of fibroblast reprogramming |
| Scientific poster |
Characterization of human limbal stem cells using acoustic focusing cytometry |
| Scientific poster |
Clinical-grade expansion of human mesenchymal stem cells using a microcarrier-based culture system under serum-free and xeno-free conditions |
| Scientific poster |
CytoTune-iPS 2.0 Sendai Reprogramming Ki for high efficiency reprogramming of fibroblasts and blood-derived cells |
| Scientific poster |
Development of feeder-free PSC culture system enabling translational & clinical research |
| Scientific poster |
Development of high-quality MSC and NSC for human disease research |
| Scientific poster |
Differentiating human pluripotent stem cells to neurons - Approaches in media development |
| |
Direct derivation and prospective isolation of Schwann cell precursors from human pluripotent stem cells |
| Scientific poster |
Effect of DGCR8 knockdown on human embryonic and adult stem cells |
| Scientific poster |
Efficient and scalable GMP-grade culture media system for rapid cardiomyocyte differentiation of pluripotent stem cells in human disease research |
| Scientific poster |
Efficient generation and characterization of neural stem cells derived from Parkinson's disease patient and age-matched control induced pluripotent stem cell lines using a novel neural induction method |
| Scientific poster |
Efficient generation of induced pluripotent stem cells derived from Parkinson's disease study patient fibroblast lines using CytoTune-iPS 2.0 Reprogramming Kit in the Essential feeder-free media system |
| Scientific poster |
Efficient induction and scale up generation of neural stem cells from human pluripotent stem cells |
| Scientific poster |
Efficient iPSC generation from various blood-derived cell types |
| Scientific poster |
Efficient method to generate vector-free induced pluripotent stem cells from CD34+ and PBMCs using the CytoTune iPS Sendai Reprogramming Kit |
| Scientific poster |
Enabling successful reprogramming of peripheral blood mononuclear cells to induced pluripotent stem cells with CytoTune-iPS 2.0 Sendai Reprogramming Kit |
| Scientific poster |
Essential 8 Medium: A xeno-free, feeder-free medium for the culture and generation of human iPSCs |
| Scientific poster |
Essential media system for reprogramming |
| Scientific poster |
Factors that enhance Sendai virus mediated somatic reprogramming |
| Scientific poster |
Generation of large number of floor plate derived, midbrain-specified DA neurons from human PSCs for scaled application |
| Scientific poster |
Generation of transgene-free iPSCs From Parkinson's disease patients |
| Scientific poster |
Generation of zero-footprint iPSCs in xeno-free or feeder-free with CytoTune-iPS Sendai Reprogramming Kit |
| Scientific poster |
Genome Editing of α-Synuclein in iPSCs from a Donor with Multiple System Atrophy |
| Scientific poster |
Genome editing of induced pluripotent stem cells from Parkinson's disease and multiple system atrophy patients |
| Scientific poster |
High-quality cGMP-manufactured human mesenchymal stem cell and neural stem cell for human disease research |
| Scientific poster |
High-quality episomal human iPSC derived from cord blood with a zero footprint: Applications in serum-free and xeno-free culture |
| Scientific poster |
Highly efficient and robust generation of neural stem cells from human pluripotent stem cells |
| Scientific poster |
Human adipose-derived stem cell characterization and comparative gene expression profiling |
| Scientific poster |
Ideal Xeno-free culture conditions for human fibroblasts that facilitate efficient reprogramming |
| Scientific poster |
Improved cryopreservation and recovery solutions for pluripotent stem cells and difficult-to-preserve primary cells |
| Scientific poster |
Integerated approach for generation of validated human iPSC banks |
| Scientific poster |
Integrated platform for creation of assay-ready neural cells |
| Scientific poster |
Large-scale and focused transcriptome analysis of integration-free induced pluripotent stem cells |
| Scientific poster |
Lipofectamine 3000: A new transfection reagent for iPSC generation and stem cell genomic engineering |
| Scientific poster |
Modulating growth factor addition to Essential 6 media for a complete xeno-free media from fibroblast culture to iPSC generation and expansion |
| Scientific poster |
Molecular analysis tools for epigenomic characterization of pluripotent stem cells |
| Scientific poster |
Novel Alkaline Phosphatase Live Stain to Identify and Isolate Emerging iPSCs |
| Scientific poster |
Novel markers to distinguish pluripotent and non-pluripotent cells |
| Scientific poster |
Novel neural induction method for efficient generation of neural stem cells dervied from Parkinson's |
| Scientific poster |
Optimization of human CD34+ cells for reprogramming using tailored media and alternate timelines |
| Scientific poster |
Optimized neuronal culture media for electrophysiology |
| Scientific poster |
Process development strategies to enable large-scale expansion of mesenchymal stem cells for cellular therapy |
| Scientific poster |
Quantitation of rare undifferentiated hESCs by methylation-specific CastPCR (MeS castPCR) |
| Scientific poster |
Rapid manufacture of custom TAL effector nucleases for genomic editing |
| Scientific poster |
Recombinant human Laminin-521 supports PSC survival in Essential 8 medium during critical transitions |
| Scientific poster |
Synthetic surfaces for the culture of human embryonic and adult stem cells |
| Scientific poster |
Synthetic surfaces for the culture of human embryonic and adult stem cells |
| Scientific poster |
TaqMan Assays for rapid assessment of genome, epigenome, and quality of integration free induced pluripotent stem cells |
| Scientific poster |
Use of surrogate reporter vectors to enrich for CRISPR- & TALEN-modified cells |
| Scientific poster |
Using cells from patients with multiple systems atrophy or Parkinson's disease (PARK2, LRRK2, and/or GBA mutations) to build stem cell-derived disease model systems |
| Scientific poster |
Utility of hPSC Scorecard Assay in assessment of functional pluripotency of cells across the iPSC workflow |
| Scientific poster |
Utilizing advanced cryopreservation techniques to produce assay ready primary mouse neurons |
| Scientific poster |
Xeno-free culture systems for pluripotent stem cells |
| Scientific poster |
Xeno-free culture systems for stem cells |
| Selection guide |
Mesenchymal Stem Cell Resource Guide |
| Selection guide |
Tools for neural cell culture of primary cells |
| Selection guide |
Neural cell culture systems |
| Selection guide |
Pluripotent Stem Cell Guidebook |
| Training |
Gibco PSC Culture Virtual Training Lab |
| Training |
Gibco PSC Workshop |
| Video |
A Thought Leader's Perspective: Unlocking cardiovascular disease with iPS cells - Dr. Chad Cowan |
| Video |
Advances in Stem Cell Research - Dr. Alexander Meissner |
| Video |
Advances in Stem Cell Research: Essential 8 Medium, A new standard for iPSC cell culture - Dr. Emile Nuwaysir |
| Video |
Alkaline Phosphatase Live Stain |
| Video |
CTS Mini-Documentary Series |
| Video |
How to adapt pluripotent stem cells from other PSC media into Essential 8 Medium |
| Video |
How to differentiate pluripotent stem cells into cardiomyocytes |
| Video |
How to induce pluripotent stem cells in to definitive endoderm |
| Video |
How to passage PSCs in Essential 8 Medium |
| Video |
How to prepare Essential 8 Medium for PSC Culture |
| Video |
How to prepare Vitronectin substrate plates for use with Essential 8 Medium |
| Video |
How to use Gibco PSC Neural Induction Medium |
| Video |
How to Use the TaqMan hPSC Scorecard Panel |
| Video |
Why we chose the TaqMan hPSC Scorecard Assay - Jennifer Moore, RUCDR/Infinite Biologics |
| Virtual event |
Gibco 24 Hours of Stem Cells virtual event |
| Web |
PSC Dopaminergic Neuron Differentiation Kit (prototype) landing page |
| Webinar |
24 Hours of Stem Cells - On-demand presentations 2014/2015 |
| Webinar |
Antibody-based tools and protocols for characterization of pluripontent stem cells |
| Webinar |
Antibodies for stem cell research |
| Webinar |
Barriers in stem cell therapy - Dr Jeanne Loring |
| Webinar |
Building a stem cell matrix - Dr Jeanne Loring |
| Webinar |
Characterization of human pluripotent stem cells - Dr. Alexander Meissner |
| Webinar |
Considerations for the culture of pluripotent stem cells |
| Webinar |
Creating integration-free iPSCs and NSCs to Model Parkinson's disease - Dr. Birgitt Schuele |
| Webinar |
Culture adaptation of pluripotent stem cells: an in vitro model for oncogensis |
| Webinar |
Culture & characterization systems for hESCs and iPSCs |
| Webinar |
Culture & characterization systems for mesenchymal stem cells (hMSC) |
| Webinar |
Development of chemically defined cell culture for human pluripotent stem cells |
| Webinar |
Differentiation of Midbrain Floor Plate Progenitors and Dopaminergic Neurons from Human Pluripotent Stem Cells |
| Webinar |
Eliminate serum to gain control of T cell research - New T cell-defined serum replacement |
| Webinar |
Epigenetic regulation in stem cells and reprogramming |
| Webinar |
Essential 8 & Essential 6 - A feeder-free, xeno-free system for reprogramming and culture of PSCs |
| Webinar |
Essential 8 Flex Medium: Eliminating daily feeding in a feeder-free, xeno-free PSC culture system |
| Webinar |
Eyeing the Single Stem Cell - Dr Jeanne Loring |
| Webinar |
Generation of transgene-free induced pluripotent stem cells - Dr Uma Lakshmipathy |
| Webinar |
Genome editing and stem cell engineering for disease modeling |
| Webinar |
Highly efficient genome editing and cell engineering in stem cells using CRISPR/Cas9 |
| Webinar |
Human neural stem cell (hNSC) platforms |
| Webinar |
Improved T cell function and in vivo engraftment of CAR-T cells expanded ex vivo with CTS Immune Cell SR |
| Webinar |
Inducing excitement with pluripotency - Dr Jeanne Loring |
| Webinar |
Identifying iPSCs with a novel Live Alkaline Phosphatase Stain |
| Webinar |
Knockout Serum Replacement – Multi-Species: Feeder-based PSC culture proven more reliable than FBS |
| Webinar |
Leaving nothing to chance - Dr Mark Tomishima |
| Webinar |
mircoRNA and epigenetic regulation of neural stem cell differentiations - Dr Ron Hart |
| Webinar |
MSC Culture & Beyond |
| Webinar |
MSC Culture Systems & Applications |
| Webinar |
Molecular engineering of biomaterial platforms for scalable stem cell manufacturing |
| Webinar |
Next-generation genome analysis tools for stem cells - Dr Michael Rhodes |
| Webinar |
Pluripotent stem cell characterization methods |
| Webinar |
Pluripotent Stem Cell Culture Systems: Identification of Appropriate Medium, Matrix, and Passaging Reagent for Your Stem Cell Workflow Needs |
| Webinar |
PSCs to cardiomyocytes in three steps |
| Webinar |
Rapid induction of neural stem cells without the need for EB formation |
| Webinar |
Reprogramming cells to study mental disorders |
| Webinar |
Stem cells as a model for morphogenesis of tissues - Dr Elaine Fuchs |
| Webinar |
Stemming the loss of species - Dr Jeanne Loring |
| Webinar |
The evolution of PSC culture media - Dr Rupa Shevde |
| Webinar |
The future of pluripotent stem cell banking |
| Webinar |
Thermo Fisher Scientific's cell therapy capabilities |
| Webinar |
Utility of gene expression signatures for the characterization of cellular identity |
| Webinar |
Xeno-free derivation and maintenance of pluripotent cell lines - Dr Jordan Pomeroy |
| White paper |
Disease modeling of hypertrophic cardiomyopathy from patients carrying sarcomeric mutations |